Sustained Improvement in Atopic Dermatitis Disease Control and Treatment Satisfaction With Dupilumab in Clinical Practice: 7-Year Follow-up Results From the RELIEVE-AD Study
SKIN The Journal of Cutaneous Medicine · 10.11.2026 · 10 (6) · s828
DOI: 10.25251/7nntvy16 ↗Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.11.2026. Verfasst von Mona Shahriari und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective: To report 7-year outcomes of dupilumab in AD disease control and treatment satisfaction from the RELIEVE-AD study.
Zitieren
APA
Shahriari, M., Yang, M., Chao, J., Martins, B., Barnum, O., Noonan, K., Shumel, B., Haddad, E., & Wang, Z. (2026). Sustained Improvement in Atopic Dermatitis Disease Control and Treatment Satisfaction With Dupilumab in Clinical Practice: 7-Year Follow-up Results From the RELIEVE-AD Study. SKIN The Journal of Cutaneous Medicine, 10(6), s828. https://doi.org/10.25251/7nntvy16
Vancouver
Shahriari M, Yang M, Chao J, Martins B, Barnum O, Noonan K, et al. Sustained Improvement in Atopic Dermatitis Disease Control and Treatment Satisfaction With Dupilumab in Clinical Practice: 7-Year Follow-up Results From the RELIEVE-AD Study. SKIN The Journal of Cutaneous Medicine. 2026;10(6):s828. doi:10.25251/7nntvy16
BibTeX
@article{Shahriari2026,
author = {Shahriari, Mona and Yang, Min and Chao, Jingdong and Martins, Bruno and Barnum, Olivia and Noonan, Kerry and Shumel, Brad and Haddad, El-Bdaoui and Wang, Zhixiao},
title = {Sustained Improvement in Atopic Dermatitis Disease Control and Treatment Satisfaction With Dupilumab in Clinical Practice: 7-Year Follow-up Results From the RELIEVE-AD Study},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2026},
volume = {10},
number = {6},
pages = {s828},
doi = {10.25251/7nntvy16}
}
EUVIMED